Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction

Although capillary leak syndrome has a high mortality rate, its trigger, diagnosis, and treatment remain a challenge to clinicians because of the poor understanding of its mechanism and lack of treatment guidelines. With the extended use of immune checkpoint inhibitors in modern oncology, immune che...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Haixia, Vlaminck, Brittany, Owoyemi, Itunu, Herrmann, Sandra M., Leung, Nelson, Markovic, Svetomir N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240169/
https://www.ncbi.nlm.nih.gov/pubmed/34195558
http://dx.doi.org/10.1016/j.mayocpiqo.2021.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240169/
https://www.ncbi.nlm.nih.gov/pubmed/34195558
http://dx.doi.org/10.1016/j.mayocpiqo.2021.01.004

Ejemplares similares